✦ LIBER ✦
Phase I/II trial of adding semisynthetic homoharringtonine in chronic myeloid leukemia patients who have achieved partial or complete cytogenetic response on imatinib
✍ Scribed by David Marin; Jaspal S. Kaeda; Catharina Andreasson; Sue M. Saunders; Marco Bua; Eduardo Olavarria; John M. Goldman; Jane F. Apperley
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 78 KB
- Volume
- 103
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.